Covaxin; WHO approval is expected in July or September: Bharat Biotech

Bharat Biotech has said that it is in the process of approving covaxin foreign licenses. The explanation comes amid rumors that delays in approvals could hamper entry into foreign countries.

Proceedings have begun for regulated licensing in 60 countries. In most countries, those who have not been vaccinated can travel with a Covid negative certificate and hope to get WHO approval in July or September, the manufacturers wrote on Twitter.

Leave a Comment